Association Between Hypnotics and Dementia: A Mini Narrative Review
- PMID: 38810994
- PMCID: PMC11136580
- DOI: 10.30773/pi.2023.0383
Association Between Hypnotics and Dementia: A Mini Narrative Review
Abstract
Objective: This narrative review aims to provide a comprehensive assessment of the existing literature on the relationship between hypnotics and dementia, considering both potential link and inconclusive or lack of association.
Methods: Data from studies that investigate the association between hypnotic medications and dementia were reviewed. Studies included both cohort studies and systematic reviews, participants with various type of dementia and hypnotics including benzodiazepines (BZDs) and Z-drugs (ZDs).
Results: The existing literatures presents conflicting evidence regarding the association between hypnotics, including BZDs and ZDs, and the risk of dementia. Some studies suggest a potential link between prolonged use of hypnotics and an increased risk of dementia. However, other studies indicate inconclusive or lacking evidence regarding this association. Factors such as study design, sample characteristics, and control of confounding variables contribute to the variability in findings.
Conclusion: The relationship between hypnotics and dementia remains complex and controversial. While some studies suggest a potential association, others find inconclusive or conflicting evidence. Future research should focus on addressing methodological limitations, considering classifying dementia subtypes, and try to adjust medication lag time.
Keywords: Benzodiazepine; Cognitive decline; Dementia; Hypnotics; Sedatives.
Conflict of interest statement
Yoo Hyun Um, a contributing editor of the
Similar articles
-
Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use.Neurotherapeutics. 2020 Jan;17(1):156-164. doi: 10.1007/s13311-019-00801-9. Neurotherapeutics. 2020. PMID: 31802436 Free PMC article.
-
Is there a link between the use of benzodiazepines and related drugs and dementia? A systematic review of reviews.Eur Geriatr Med. 2022 Feb;13(1):19-32. doi: 10.1007/s41999-021-00553-w. Epub 2021 Aug 17. Eur Geriatr Med. 2022. PMID: 34403113
-
Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study.PLoS Med. 2021 Jul 15;18(7):e1003709. doi: 10.1371/journal.pmed.1003709. eCollection 2021 Jul. PLoS Med. 2021. PMID: 34264928 Free PMC article.
-
Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers.JAMA Netw Open. 2019 Apr 5;2(4):e191435. doi: 10.1001/jamanetworkopen.2019.1435. JAMA Netw Open. 2019. PMID: 30951155 Free PMC article.
-
Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: A systematic review and meta-analysis.Sleep Med Rev. 2019 Dec;48:101214. doi: 10.1016/j.smrv.2019.101214. Epub 2019 Oct 1. Sleep Med Rev. 2019. PMID: 31648145
References
-
- Palagini L, Hertenstein E, Riemann D, Nissen C. Sleep, insomnia and mental health. J Sleep Res. 2022;31:e13628. - PubMed
-
- Ma TT, Wang Z, Qin X, Ju C, Lau WCY, Man KKC, et al. Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008 to 2018: a sales data analysis. Sleep. 2023;46:zsad124. - PubMed
-
- Machado FV, Louzada LL, Cross NE, Camargos EF, Dang-Vu TT, Nóbrega OT. More than a quarter century of the most prescribed sleeping pill: systematic review of zolpidem use by older adults. Exp Gerontol. 2020;136:110962. - PubMed
-
- De Crescenzo F, D’Alò GL, Ostinelli EG, Ciabattini M, Di Franco V, Watanabe N, et al. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022;400:170–184. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources